AbbVie Newsroom

Redburn Atlantic Adjusts AbbVie's Price Target to $216 From $215, Keeps Buy Rating

MT NewswiresNov 15 12:44 ET

AbbVie Analyst Ratings

BenzingaNov 15 05:10 ET

Wolfe Research Initiates AbbVie(ABBV.US) With Buy Rating, Announces Target Price $205

Moomoo NewsNov 14 16:31 ET

AbbVie Initiated With an Outperform at Wolfe Research

TipRanksNov 14 16:13 ET

Deutsche Bank Adjusts Price Target on AbbVie to $177 From $180, Keeps Hold Rating

MT NewswiresNov 14 07:04 ET

AbbVie Is Maintained at Overweight by JP Morgan

Dow JonesNov 13 10:10 ET

AbbVie Analyst Ratings

BenzingaNov 13 10:03 ET

J.P. Morgan Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $200

Moomoo NewsNov 13 07:32 ET

AbbVie Hold Rating Maintained Amid Emraclidine Trial Challenges and Competitive Pressure

TipRanksNov 13 02:11 ET

UBS Maintains AbbVie(ABBV.US) With Hold Rating, Cuts Target Price to $181

Moomoo NewsNov 12 14:32 ET

AbbVie Is Maintained at Buy by Citigroup

Dow JonesNov 12 14:08 ET

BMO Capital Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $208

Moomoo NewsNov 12 09:35 ET

AbbVie Is Maintained at Overweight by Morgan Stanley

Dow JonesNov 12 08:39 ET

AbbVie Analyst Ratings

BenzingaNov 12 08:31 ET

Citi Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $215

Moomoo NewsNov 12 06:35 ET

Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $224

Moomoo NewsNov 12 06:35 ET

AbbVie Buy Rating Affirmed Despite Emraclidine Setback, Driven by Skyrizi and Rinvoq Growth

TipRanksNov 12 06:12 ET

BMO Capital Adjusts Price Target on AbbVie to $208 From $228, Maintains Outperform Rating

MT NewswiresNov 12 05:46 ET

Citigroup Adjusts AbbVie Price Target to $215 From $226

MT NewswiresNov 11 10:51 ET

Barclays Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $212

Moomoo NewsNov 11 10:33 ET